Tvardi Therapeutics Inc. advanced stock charts by Barron's. View TVRD historical stock data and compare to other stocks, and exchanges.

Payal Sahni Becher is currently the Chief People Experience Officer & Executive VP at Pfizer Inc. She started this position in 2022. Prior to her current role, she obtained a graduate degree from ...

Consolidation is likely to continue, with the indices attempting to defend the previous Thursday’s low in the upcoming ...

Pfizer is an attractive value play, trading at a significant discount despite strong profitability and growth fundamentals ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...

Pfizer can get out of its recent troubles thanks to a deep pipeline and cost-cutting efforts. Medical Properties Trust has ...

According to Benzinga Pro, Pfizer's peer group average for short interest as a percentage of float is 3.60%, which means the ...

The market is likely to continue trading in a range within last Thursday’s high and low. Below are some short-term trading ...

Pfizer jumps into cancer-treatment race with a $6 billion licensing deal with a China-based company, six months after Merck’s ...

Pfizer PFE announced that it is in-licensing global development and commercialization rights, ex-China, to SSGJ-707, a ...

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32% YoY; bed additions, higher Arpob and international ...